ACTRN12626000902392进行中（未招募）不适用
Sensitivity and acceptability of the SpiroNose® device for diagnosing patients with respiratory symptoms or lung abnormalities or sleep disorders: a prospective multicentre study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 主要目的
- Diagnostic
入排标准
- 年龄范围
- 18 Years 至 No limit（—）
- 性别
- All
入选标准
- •Patients attending routine respiratory, sleep or lung assessment are potentially eligible if aged 18 years or over, are willing to provide written informed consent AND have any chronic respiratory or sleep symptoms (cough, wheeze, shortness of breath, chest tightness, haemoptysis) or diagnoses that may cause or contribute to respiratory symptoms (including but not limited to asthma, COPD, lung cancer, interstitial lung abnormalities, cardiac failure, obstructive sleep apnoea or narcolepsy) and/or have abnormalities on lung imaging.
- •Adults in the community may be eligible as controls if they are aged 18 years or over, provide written informed consent, and do not have any of the symptoms or conditions listed above.
排除标准
- •Potential participants will be excluded from enrolment in the study if they have:
- •Any condition that interferes with their ability to understand the study requirements.
- •Any condition with a life expectancy of less than 6 months
研究者
相似试验
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
进行中（未招募）
3 期
NN9838-7910: A research study to look at how two different doses of CagriSema and one dose of semaglutide help people living with obesity with or without type 2 diabetes lose weightNutritional, Metabolic, EndocrinePACTR202607641626021Novo Nordisk120
招募中
2 期
A trial to determine the safety and tolerability of transplanted stem cellderived dopamine neurons to the brains of individuals with Parkinson's Disease.Parkinson's disease2024-511237-35-00Region Skane4
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96
进行中（未招募）
1/2 期
A Study To Evaluate The Effect Of Epigea Repens In People With Renal StoneCTRI/2026/07/113340Sainath Hospital35